Neurodegenerative Pathways in Parkinsons Disease: Therapeutic Strategies

Author(s): S. M. Cardoso, P. I. Moreira, P. Agostinho, C. Pereira, C. R. Oliveira

Journal Name: Current Drug Targets - CNS & Neurological Disorders
Continued as CNS & Neurological Disorders - Drug Targets

Volume 4 , Issue 4 , 2005


Parkinsons disease (PD), considered one of the major neurological disorders, is characterized by the loss of dopaminergic neurons in the pars compacta of the substantia nigra and by the presence of intraneuronal cytoplasmic inclusions called Lewy bodies. The causes for degeneration of PD neurons remain unclear, however, recent findings contributed to clarify this issue. This review will discuss the current understanding of the mechanisms underlying Parkinsons disease pathogenesis, focusing on the current and potential therapeutic strategies for human treatment.

Keywords: synuclein, neuronal circuits, oxidative stress, mitochondria, proteasome, neuroinflammation, cell death, therapeutics

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Published on: 01 March, 2012
Page: [405 - 419]
Pages: 15
DOI: 10.2174/1568007054546072
Price: $65

Article Metrics

PDF: 2